Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 05, 2025 05:41 ET | Source: Research and Markets

CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035: Distribution by Target Antigens, Target Indication, Key Geographies, Sales...
December 05, 2025 04:16 ET | Source: Research and Markets

$3.5 Bn Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035 Cell Therapy, Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Cell Therapy, Type of Genetic Modification,...
December 01, 2025 09:46 ET | Source: Research and Markets

CAR-T Cell Therapy Forecast Report 2025: A $13.25 Billion Market by 2030, Driven by Rising Cancer Incidence, Strong Efficacy in R/R Patients, and Growing R&D Investment

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "CAR-T Cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 27, 2025 08:57 ET | Source: Research and Markets

Fibroblast Activation Protein (FAP) Targeted Therapy Competitor Analysis Report

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Fibroblast Activation Protein (FAP) Targeted Therapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering. This...
November 27, 2025 08:43 ET | Source: Research and Markets

KLK2-Targeted Immunotherapies Pipeline Competitive Intelligence Report 2025

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of KLK2-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
November 27, 2025 08:18 ET | Source: Research and Markets

IGF-1R- and IGF-1 Targeted Immunotherapy Pipeline and Competitive Intelligence Report 2025: Oncology Applications Using Biomarker-driven Patient Stratification and Combination Treatments

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of IGF-1R- and IGF-1 Targeted Immunotherapy" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
November 21, 2025 07:07 ET | Source: Research and Markets

U.S. Cell and Gene Therapy CDMO Market Trends Analysis Report 2025-2033: Gene & CAR-T Therapy Boom Drives Demand for CDMO Partnerships and Specialized Manufacturing Capacity

Dublin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The "U.S. Cell and Gene Therapy CDMO Market Size, Share & Trends Analysis Report by Phase (Pre-clinical, Clinical), Product (Gene Therapy, Cell Therapy,...
November 05, 2025 15:20 ET | Source: Tevogen Bio Inc

Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID

This milestone expands patient eligibility through multi-HLA targetingBuilds on completed TVGN 489 trial demonstrating 100% viral clearance, no reinfections, and no cases of Long COVID in high-risk...
October 29, 2025 12:35 ET | Source: Tevogen Bio Inc

Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress

WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), in ongoing community, industry, and academic engagements, has continued to...
October 22, 2025 10:44 ET | Source: Research and Markets

T-Cell Malignancies Pipeline Research Report 2025: Market Opportunities with Over 75 Companies and 80+ Drugs, Exploring Novel Treatments Like CAR-T Therapies and Targeted Therapies

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "T-Cell Malignancies - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report offers in-depth analysis of over 75...